Access Genetics — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Access Genetics and OralDNA Labs are leaders in the personalized diagnostics space, focusing on salivary and DNA-based testing. Their business model combines direct-to-provider diagnostic services with a technology-enabled PartnerLab program, which provides cloud-based TeleGene software and LabKit materials to support other laboratories. With a strong emphasis on customer service and a national operational footprint from their Eden Prairie, MN headquarters, they aim to make advanced molecular diagnostics more accessible.

DiagnosticsOral HealthPersonalized Medicine

Technology Platform

Proprietary cloud-based TeleGene software and LabKit materials that enable third-party laboratories to offer advanced DNA and salivary diagnostics through their PartnerLab program.

Opportunities

Growth opportunities include expanding the diagnostic test menu into new therapeutic areas like pharmacogenomics, scaling the PartnerLab program to international markets, and forming strategic alliances with large dental service organizations or hospital networks to drive test volume.

Risk Factors

Key risks include regulatory changes in laboratory reimbursement (CMS, private payors), intense competition from larger national reference laboratories, technological disruption from new testing modalities, and potential over-reliance on the dental market segment.

Competitive Landscape

Main competitors include large commercial labs (Quest Diagnostics, LabCorp), specialized molecular diagnostic companies, and point-of-care testing developers. Access Genetics differentiates through its combined service-provider and technology-enabler (PartnerLab) model, along with the strong OralDNA brand in salivary diagnostics.

More companies in Diagnostics & Precision Medicine →More companies in United States →